Last Posted: Jun 08, 2017
Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.
Crook Ashley et al. Amyotrophic lateral sclerosis & frontotemporal degeneration 2017 Jun 1-11
Evaluating a Gene-Environment Interaction in Amyotrophic Lateral Sclerosis: Methylmercury Exposure and Mutated SOD1.
Bailey Jordan M et al. Current environmental health reports 2017 Jun 4(2) 200-207
A New Drug for A.L.S., but the Diagnosis Remains Dire
JE Brody, New York Times, May 29, 2017
Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature.
Tarolli Christopher G et al. Tremor and other hyperkinetic movements (New York, N.Y.) 2017 7454
Research Moves the Fight Against ALS Forward
Clinical Trials and Studies Using the National Amyotrophic Lateral Sclerosis Registry
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.